drugset / Trial / NCT00125749
Vaccination of Patients With Stage IV Melanoma With Dendritic Cells
Phase 1/2
Completed
30 enrolled
Baylor Research Institute
Mary Crowley Medical Research Center · collabODC Therapy · collab
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to test a novel dendritic cell (DC) vaccine in patients with Stage IV melanoma.
Timeline
- Start
- 2005-07
- Primary completion
- 2007-06
- Completion
- 2007-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dendritic Cell Vaccination | Vaccine | — | Other |